Just before turning the page to 2026, it’s worth pausing to reflect on both the progress made and the challenges that remain in the fight against antimicrobial resistance (AMR). The numbers, unfortunately, haven’t changed. According [...]
More news
Photos: NCCR AntiResist June 28th 2024 – INCATE, the INCubator for Antimicrobial Therapies in Europe, [...]
Just two days before the 8th AMR Conference opened its doors, the INCATE Selection Committee [...]
The AMR conference has established itself as the premier European conference on the topic of [...]
Basel was definitely the place to be in the week of 4th-8th March! Not only [...]
Basel is the place to be this week, and believe us when we say it [...]
February 2024 – Xiretsa, Inc is the second selected venture to receive INCATEs Stage II [...]
Do you have an outstanding antimicrobial resistance (AMR) innovation that you would like to share [...]
After receiving over 40 applications and going through a rigorous decision process, the finalists for [...]
